Medicare shelled out $5.7 billion on Ozempic and other similar diabetes drugs in 2022, up from $57 million in 2018, according to a new KFF analysis.The pricey medications, which include Mounjaro and ...
Medicare shelled out $5.7 billion on Ozempic and other similar diabetes drugs in 2022, up from $57 million in 2018, according to a new KFF analysis. The pricey medications, which include Mounjaro and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback